chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a nurse practitioner refers to a patient of unknown age. On 31-MAY-2013, the patient was vaccinated with the first dose of GARDASIL (dose, route and lot number were not reported). On 29-JUL-2013, patient was vaccinated with the second dose of GARDASIL (dose, route and lot number were not reported) and on 18-OCT-2013 the patient was vaccinated with the third dose of GARDASIL (dose, route and lot number were not reported). No concomitant medications were reported. The nurse practitioner stated that the patient received doses of GARDASIL at less than minimum intervals. Nurse practitioner stated that doses were administered in an unspecified location. No adverse effects reported.
Patient told me that he gets dizzy after immunizations. I told him that I would keep him seated after until he felt ok, his wife was with him and I told her that if he started feeling bad to let me know as I went back into the pharmacy.  About 5 minutes after his immunization he said he didn't feel well.  I went out to check on him he said he was hot  and then he lost consciousness.  His wife and I were not able to wake him,  911 was called and  I grabbed the Epipen 0.3mg and gave him 1 dose in the left thigh.  Shortly after he started to respond.  Once awake he began vomiting and still complained of being very hot.  His wife splashed water on his face and we kept talking to him until EMS arrived about 5 minutes after the Call.  EMS  checked him out, he refused to go to the hospital and refused them to take him to his car when he felt better.  He walked out on his own after about another 20 minutes with his wife.  I called to check on his around 4pm and he said that he was feeling ok.
Pain (a lot more than other vaccines) at injection site; Moderate to severe soreness in arm; Numbness/tingling in arm up to 4 h after injection; Numbness/tingling in arm up to 4 h after injection; Limited arm mobility; Bruising at injection site (bruising still visible after 5 days); This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Aug2021 at 15:00 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. Medical history included eczema. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient's any other medications within two weeks was reported as not applicable. On 05Aug2021 at 15:00, the patient experienced pain (a lot more than other vaccines) at injection site, moderate to severe soreness in the arm, numbness/tingling in the arm up to 4 hours after injection, limited arm mobility and bruising at the injection site (bruising was still visible after 5 days). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events numbness/tingling in arm up to 4 h after injection was resolved on 05Aug2021 at 19:00. The clinical outcome of the events pain (a lot more than other vaccines) at injection site, moderate to severe soreness in arm, limited arm mobility was resolved on an unknown date in Aug2021. The clinical outcome of the event bruising at injection site (bruising was still visible after 5 days) was not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Employee received ADACEL inj (as offered by employer) on 11/20/08.  Next night noticed a golf ball sz., red, warm lump at inj site.  ER visit plus walk-in clinic visit.  Antibiotic Px'd. Quarter sz deep lump remains.
Vaccine expired 11-2-20. PPD test was administered  11-07-20.
Moderna 2/19/21, 3/19/21, 10/24/21, 3/31/22, 9/16/22. Positive on 12/24/22
Entire front of right thigh reddened and swollen.  DTaP was administered in this thigh. Onset day after vaccine administration.  Patient treated with oral antihistamine and topical hydrocortisone.
Pt first noticed a mild headache and feeling hot. Then she noticed a rash just below her jawline going down her neck and a few spotty patches to bilateral upper arms. Pt reported her symptoms to Nurse shortly after. Pt examined and vital signs taken: BP 145/101, HR 125, T 97F. Pt was given 25 mg OTC BENADRYL. Pt's vital were rechecked at 1030: BP 151/109, HR 88, T 97F.  Pt was still c/o headache (5/10) with mild nausea and rash was slowly disappearing. Pt then ate lunch and vitals rechecked at 1330: BP 148/98, HR 94, T 96.7 F with rash completely. Pt sent home to relax.
Extreme fatigue at first, then fever, chills, body aches, skin sensitivity, headache, some nausea. Lasted about 40 hours.
Had febrile seizure approximately 12 hrs after vaccines. Temp 104. Seizure lasted 15 mins. Went to ER - normal labs. Seen 11/23/10 normal exam.
pt recvd vax & had red area on abdo & chest w/ macular papular areas w/in the erythemous area; had red nodules on each leg at vax sites; seen by MD;
Site: Bruising at Injection Site-Mild, Site: Pain at Injection Site-Mild, Systemic: Body Aches Generalized-Mild, Systemic: Fever-Mild, Systemic: Headache-Mild
Rash - Information has been received from an employee of the Idaho Immunization Program who was informed by a nurse that a child was vaccinated with measle virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) on approximately 15-May-2000.  Subsequently, on approximately 15-May-2000 the patient experienced a "full-body rash".  Unspecified medical attention was sought.  Additional information has been requested.
pt devel severe asthma which has been resistant to tx;pt is an allergic person;
Patient developed meningoencepalitis, altered mental status requiring intubation.  Also developed fever.  Unknown whether this is related to vacciation.  Cause of meningoencephalitis still unknown at this time. 11/10/08-DC Summary received for DOS 10/5-10/11/08-DC DX: Viral encephalitis. Presented with first time seizure on day of admission, generalized tonic clonic seizure was incontinent of urine, declining mental status and electively intubated. Mechanical ventilation. Febrile.   12/17/09-records received-fight/altercation at school, more sleepy, fell off couch with shaking movements observed,  foaming at mouth, incontent of urine. Minimally responsive-intubated. Unresponsive to painful stimuli.
This client was given a pediatric vaccine instead of the adult adolescent vaccine. Patient did not show any symptoms of an adverse event.
This case was reported by a physician via other manufacturer and described the occurrence of influenza-like symptoms in a adult patient who received SHINGRIX for prophylaxis. In September 2018, the patient received SHINGRIX. On an unknown date, less than a month after receiving SHINGRIX, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was unknown. It was unknown if the reporter considered the influenza-like symptoms to be related to SHINGRIX. Additional details were reported as follows: This case was reported by the patient's friend. The age at vaccination was not reported. The age group was not reported but was selected as adult as per vaccine indication. The patient received SHINGRIX 2 weeks before the date of reporting to other manufacturer. The patient experienced unspecified flu like symptoms. No additional information was provided.
Pt. received 0.5mL dose of FLUZONE when it should have been 0.25 mL dose. No effects noted. Followed up next day after injection -> mthr. reported no fever, no malaise, no redness or swelling.
After Dose 1 (given 03/14/2021): EXTREME fatigue/exhaustion; sleeping 5-6 hours during the day Daily migraine-like headaches Brain Fog Memory Loss  After Dose 2 (given 4/11/2021): EXTREME fatigue/exhaustion; sleeping 3-4 hours during the day Frequent headaches Brain Fog Memory Loss Joint Pain Extreme Lower Back Pain Numbness and tingling in arms and hands One bout of paralyzation for 6-7 hours (seen in ER)
pt recvd vax & had localized rxn around inject site; swollen & tender;
Full body burning rash spread over my entire body over the course of about 24 hours. It started around my ankles and lower legs (Thursday night) which made me initially think something had bitten me in my sleep. However it progressed rapidly throughout the day Friday to the point where my palms and the soles of my feet were raging with burn. my arms, top of hands, fingers, legs, top of feet, all were covered and burning/itching. I finally went to the hospital after trying topical creams with no success.
0900 5/25/21: Suddenly started sweating profusely, nausea, tachypnea, chills, neuropathy in all extremities, and vision blacked out about 10-15 times in a row. After about 15 minutes, I was able to get back to bed. Temperature was 97.4 F at this time. This was the most concerning grouping of adverse symptoms after receiving the Moderna vaccine. PCP and cardiologist agree that this was a circulatory issue. Ever since, my tachycardia and shortness of breath have worsened. Heart rate was up to 120's with Long Covid prior to vaccine and was improving. Now up to 160's post-vaccine, hypotensive, and unable to work.
This spontaneous report was received from a nurse and refers to a multiple unspecified patients of unknown age and gender. No information about the patients' pertinent medical history, concurrent conditions, concomitant medications, drug reactions or allergies was provided. On multiple unspecified dates, the patients were vaccinated with an improperly stored doses of GARDASIL (dose, route of administration, lot# and expiration date were not reported). No adverse effects were reported. This is one of two reports from the same reporter. Additional information has been requested.
subsequent blood donation to the blood ctr in 1994 &1995 resulted in permanent deferral (lifetime) from future donations d/t hep b core antibodies;testing by pvt MD a/ & p/hep b series is negative for hep b & have no known exposure of risk
Fri 9/23: Headache, nausea, dizzy, 2-3 red spots on back; Treatment: Children's Ibuprofen; Symptoms continued throughout the day plus weakness, 103.5 fever, paleness; Treatment: Children's acetaminophen Sat 9/24: same symptoms, more red spots on torso, front and back; Treatment: Children's acetaminophen; Sun 9/25 - same symptoms except no fever, torso covered with red spots which also spread to neck and a couple on side of face; Mon 9/26 - rash only Tues 9/27 - symptom free
Severe pain under right knee for a few days. Then the following night I had a 101 fever with vomiting. The severe knee pain was gone after that. A week later I had several sores on my tongue.
Information has been received from a Licensed Practical Nurse concerning an unspecified amount of patients. Patient demographics, medical histories, concurrent conditions and concomitant medication usage were not provided. From 06-APR-2017 to 06-JUN-2017 an unspecified amount of patients received improperly stored doses of vaccines. The temperature excursions ranged from 32 degrees Fahrenheit to 35 degrees Fahrenheit. Time frame = 528 hours. There was no previous temperature excursion. The findings were not the result of a data logger. The vaccines involved included the following: PNEUMOVAX 23 lot # M037533, expiration date 17-MAY-2018; GARDASIL 9 Lot# M018810, expiration date 28-MAY-2018; ROTATEQ Lot# M031802, expiration date 09-NOV-2017; VAQTA Lot# M038572, expiration date 11-MAY-2018; RECOMBIVAX HB Lot# L023387, expiration date 22-JUN-2017 and Lot# M037771, expiration date 21-FEB-2019.  No adverse effects were reported. Additional information is not expected as the reporter stated that there was no further information to provide.
her left arm just hurts; vaccines should have been administerd subcutaneously but one was administered intramuscularly/the patient was told it was MMR vaccine; The spontaneous report was received from a 27-year-old female patient who reported on herself. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 10-APR-2019, the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) lot # N023956, expiration date: 01-SEP-2019 in the left arm (formulation, strength, dose were not reported), measles, mumps, rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) albumin status of recombinant human albumin (rHA), lot number R019391 (verified as valid) or RO19391 (RO19391 verified as non-valid), expiration date 05-JUL-2020, in the left arm (formulation, strength, dose, route of administration were not reported) and reconstituted with sterile diluent (STERILE DILUENT) as a requirement for work. On 10-APR-2019, the patient realized when she got home that both vaccines should be administered subcutaneously but one was administered intramuscularly. When she called to the pharmacy, to ask about routes of administration, she was told that measles, mumps, rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) had been given intravenously, however the person she spoke did not seem too sure about it. The patient reported, that she was fine, but her left arm just hurt (start date: 10-APR-2019). The outcome of pain in extremity was unknown. The relatedness between measles, mumps, and rubella (Wistar RA 27-3) virus vaccine, live (M-M-R II) and varicella virus vaccine live (Oka/Merck)(VARIVAX), sterile diluent and pain in the extremity was not reported.
Consumer reports that 2 weeks following 1st vaccine, he began to experience post nasal drip, sneezing, cough, runny nose. These symptoms are still persistent and he believes might be vaccine related.
Pain in shoulder. Pain when I lift arm for 1 week. Happen 2 years ago too.
tested positive for Covid, loss of smell, fatigue, congestion and she was coughing for a few days; tested positive for Covid, loss of smell, fatigue, congestion and she was coughing for a few days; This is a spontaneous report from a contactable pharmacist for self. This 39-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL0140, Expiration Date 31Mar2021) via unspecified route of administration on 23Dec2020 at single dose for COVID-19 immunization. The patient medical history and concomitant mediations not provided. The pharmacist got her first dose on 23Dec2020. On 01Jan2021, the patient developed symptoms: loss of smell, fatigue, congestion and she was coughing for a few days. She tested positive for COVID on 04Jan2021. She was cleared to go back to work and is mostly symptom free except for the loss of smell.  She is supposed to get her second vaccine tomorrow on 13Jan2021. The pharmacist asked if she can get it. The outcome of event was resolving.; Sender's Comments: Based on the information currently available, a lack of efficacy with BNT162B2 in this patient cannot be completely excluded.
Nausea, exhaustion, wheezing, eyelids swelled and .  Eyeballs felt like they would bust, sensitivity to light.  Arm swelling.  Dizziness, headaches that felt like sharp knit wing stabbed in my head.  Neck sore.
COVID PNEUMONIA; LETHARGIC; SORE ARM; This spontaneous report received from a consumer concerned a 67 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: none. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018 expiry: UNKNOWN) dose was not reported, 1 total (dose 1) administered on 13-MAR-2021 for covid-19 prophylaxis. Age at time of vaccination 67 years old. No concomitant medications were reported.  On 13-MAR-2021, the patient experienced little lethargic and sore arm (about as bad as a tetanus shot) after the shot but nothing major. On 13-JAN-2022, the patient experienced covid pneumonia, and was hospitalized (date unspecified). Duration and discharge information were not provided. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from covid pneumonia, lethargic, and sore arm. This report was serious (Hospitalization Caused / Prolonged). This report was associated with product quality complaint: 90000242584. This case, from the same reporter is linked to 20220733196.; Sender's Comments: V0: 20220733188 -COVID-19 VACCINE AD26.COV2.S- COVID PNEUMONIA. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.
After vaccine patient passed out.  Patient came to and drank some juice, then passed out again for a few seconds
Headache, muscle aches, fever, tiredness, bloody nose, ear inflammation, nausea, loss of appetite.
I received the vaccine on Sunday, May 2, 2021 around 12 noon. On Monday, May 3, 2021 around 6pm, I started to get horrendous and unusual menstrual cramping and heavy bleeding. I hoped the cramping would stop but it continued to the point that I felt I may have to go to urgent care. I took 4 ibuprofen and did no feel any relief until almost 10pm. I was extremely concerned about the cramping and heavy bleeding, both of which are unusual for me. I woke up on Tuesday, May 4, 2021, and the cramping has subsided but the heavy bleeding continues.
Long-lasting muscle pain in the left deltoid where the vaccine was administered.  Pain is still there over 2 months after the vaccination.
Symptoms occurred right away and/or developed in the next days.  Right away felt arm getting sore; patient did not take any medicine.  The next day on the face--on the nose bridge across cheek to cheek--was bright red next; redness lasted 2 or 3 days.  On the left arm had pain at site of injection and noticed bruising from left arm to breast--like if someone beat her.  Patient went to Urgent Care on 5/26; they specified vaccine had hit a capillary.   Then the next day afternoon, diarrhea and severe vomiting started; had 4 episodes of vomiting during the day and during the night also had more diarrhea.  Patient took Aleve at night and morning for swelling and pain. Patient did not take any medicine for diarrhea or nausea.  Patient sent message to doctor, and contacted pharmacist who advised patient to contact us.   Today, patient reports vaccination site and arm still are sore. Since yesterday, it also feels like patient has sore throat and cold.  Underarm 1-2 bruise spots are still visible.
Patient received Moderna vaccine and began to feel palpitations shortly after. Patient was admitted to the emergency department and seen by the provider. Provider ordered levels for potassium, TSH, and chest x-ray. Everything came back normal. Patient was discharged same day.   Patient is aware that if symptoms worsen or if there is any problem, to return to the emergency department.
Pt recvd a dose of Engerix-B & exp h/a, dizziness, & nausea;
Arm soreness in her vaccination arm after the 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm soreness in her vaccination arm after the 2nd dose) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 011L22A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2021, the patient experienced VACCINATION SITE PAIN (Arm soreness in her vaccination arm after the 2nd dose). At the time of the report, VACCINATION SITE PAIN (Arm soreness in her vaccination arm after the 2nd dose) outcome was unknown.            No concomitant medications reported. No treatment medications reported.   This case was linked to MOD-2021-403991 (Patient Link).
Pat. remarked of tickle sensation upon admin. of vac. Upon reviewing inj. soreness protocol, pat. experienced small seizure for approx. 5-7 sec. Pat. then became aware, had facial sweating, gone pale, and remarked "he didn't feel good". Tried to get BP reading. 911 had been called. EMTs arrived. BP/Pulse taken. Pat. was better before EMTs arrived, thus Pat. did not need to be escorted. EMTs ETA 5 min.
About 6 hours after the vaccine, she was off on her eating.  During the night she was fussy and up and down.  This am at about 0800 mom got her up and she noted that her skin "was on fire", she could not find her thermometer.  Her left arm was swollen to the elbow and her face was swollen.  She had begun to cough and her nose was running.  She was seen in the office this am at about 0900 and she was harsh in her breath sounds with occasional expiratory wheeze.  Mom had given her Ibuprophen 1 tsp  and the swelling in the leftand e face was gone by the time that she was seen.  There were two small red areas, about 1/2 cm in diameter at the site of injections.  There was an area about the same size was below the site of injections, but this was not an injection site.  The area on the right arm where the MMR was given had no erythema.
Child had seizure - decided was due to increased temp. Virus going around per ER physician. Did not follow up with private MD.